Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
CorMedix Inc
CRMDCurrent price
8.50 USD
+0.36 USD (+4.42%)
Last closed
6.07 USD
Company
www.cormedix.com
ISIN
US21900C3088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
499 944 416 USD
Yield for 12 month
+59.47 %
1Y
3Y
5Y
10Y
15Y
CRMD
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey. Address: 300 Connell Drive, Berkeley Heights, NJ, United States, 07922
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.50 USDP/E ratio
–Dividend Yield
–Current Year
+43 472 170 USD
Last Year
–
Current Quarter
+31 209 936 USD
Last Quarter
+11 456 115 USD
Current Year
+40 281 636 USD
Last Year
-205 562 USD
Current Quarter
+30 034 377 USD
Last Quarter
+10 769 517 USD
Key Figures CRMD
1 year
3 years
5 years
10 years
EBITDA
-22 046 608 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-13.91 %
PEG Ratio
–
Return On Equity TTM
-23.17 %
Wall Street Target Price
15.50 USD
Revenue TTM
43 472 168 USD
Book Value
1.31 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-47.30 %
Dividend Yield
–
Gross Profit TTM
40 281 636 USD
Earnings per share
-0.30 USD
Diluted Eps TTM
-0.30 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-41.25 %
Dividend Analytics CRMD
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History CRMD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
26.03.2019
Stock Valuation CRMD
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
10.95
Enterprise Value Revenue
10.32
Price Sales TTM
11.50
Enterprise Value EBITDA
-3.50
Price Book MRQ
5.91
Financials CRMD
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CRMD
For 52 weeks
3.61 USD
13.85 USD
50 Day MA
9.11 USD
Shares Short Prior Month
8 179 030
200 Day MA
8.45 USD
Short Ratio
3.97
Shares Short
7 924 601
Short Percent
12.17 %
BeatStart